Peer Review reports
From: The role of sialomucin CD164 (MGC-24v or endolyn) in prostate cancer metastasis
| Original Submission | ||
|---|---|---|
| 25 Jan 2006 | Submitted | Original manuscript |
| 3 Feb 2006 | Author responded | Author comments - Russell Taichman |
| Resubmission - Version 2 | ||
| 3 Feb 2006 | Submitted | Manuscript version 2 |
| 15 Feb 2006 | Reviewed | Reviewer Report - Eva Corey |
| 6 Mar 2006 | Reviewed | Reviewer Report - Suzanne Watt |
| 1 Apr 2006 | Author responded | Author comments - Russell Taichman |
| Resubmission - Version 3 | ||
| 1 Apr 2006 | Submitted | Manuscript version 3 |
| 11 Apr 2006 | Reviewed | Reviewer Report - Eva Corey |
| 19 May 2006 | Reviewed | Reviewer Report - Suzanne Watt |
| 14 Jun 2006 | Author responded | Author comments - Russell Taichman |
| Resubmission - Version 4 | ||
| 14 Jun 2006 | Submitted | Manuscript version 4 |
| 3 Jul 2006 | Reviewed | Reviewer Report - Suzanne Watt |
| 6 Jul 2006 | Author responded | Author comments - Russell Taichman |
| Resubmission - Version 5 | ||
| 6 Jul 2006 | Submitted | Manuscript version 5 |
| 17 Jul 2006 | Author responded | Author comments - Russell Taichman |
| Resubmission - Version 6 | ||
| 17 Jul 2006 | Submitted | Manuscript version 6 |
| 18 Jul 2006 | Author responded | Author comments - Russell Taichman |
| Resubmission - Version 7 | ||
| 18 Jul 2006 | Submitted | Manuscript version 7 |
| Publishing | ||
| 21 Jul 2006 | Editorially accepted | |
| 21 Jul 2006 | Article published | 10.1186/1471-2407-6-195 |
You can find further information about peer review here.